Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Burrell

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
The Medical Journal of Australia|November 12, 1983
Hepatitis B reservoirs and attack rates in an Australian community. A basis for vaccination and crossinfection policiesC J Burrell, A S Cameron, G Hart, et al.
Current Drug Targets|December 16, 2006
Cellular interactions of virion infectivity factor (Vif) as potential therapeutic targets: APOBEC3G and more?J M Carr, A J Davis, F Feng, et al.
Journal of Virological Methods|January 1, 1990
Use of recombinant hepatitis delta antigen in diagnostic assays for HDV antibodyE J Gowans, T B Macnaughton, L Mickan, et al.
Virology|December 15, 1996
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducksA R Jilbert, D S Miller, C A Scougall, et al.
The Journal of General Virology|June 1, 1990
Stable expression of hepatitis delta virus antigen in a eukaryotic cell lineT B Macnaughton, E J Gowans, B Reinboth, et al.
British Medical Journal|October 7, 1972
Rheumatoid arthritis, rheumatoid factor, and tests for Australia or hepatitis-associated antigenC J Burrell, J D Dickson, H Gerber, et al.
Virus Research|August 1, 1990
Serological analysis of duck hepatitis B virus infectionM Qiao, E J Gowans, S E Bailey, et al.
American Journal of Clinical Pathology|February 1, 1992
Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologiesG D Higgins, D M Uzelin, G E Phillips, et al.
Cancer|July 1, 1992
High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasiaG D Higgins, G E Phillips, L A Smith, et al.
BMJ (Clinical Research Ed.)|January 27, 1990
Districts' use of thrombolytic agentsC J Burrell, J D Skehan, M L Cowley, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
The Medical Journal of Australia|November 12, 1983
Hepatitis B reservoirs and attack rates in an Australian community. A basis for vaccination and crossinfection policiesC J Burrell, A S Cameron, G Hart, et al.
Current Drug Targets|December 16, 2006
Cellular interactions of virion infectivity factor (Vif) as potential therapeutic targets: APOBEC3G and more?J M Carr, A J Davis, F Feng, et al.
Journal of Virological Methods|January 1, 1990
Use of recombinant hepatitis delta antigen in diagnostic assays for HDV antibodyE J Gowans, T B Macnaughton, L Mickan, et al.
Virology|December 15, 1996
Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducksA R Jilbert, D S Miller, C A Scougall, et al.
The Journal of General Virology|June 1, 1990
Stable expression of hepatitis delta virus antigen in a eukaryotic cell lineT B Macnaughton, E J Gowans, B Reinboth, et al.
British Medical Journal|October 7, 1972
Rheumatoid arthritis, rheumatoid factor, and tests for Australia or hepatitis-associated antigenC J Burrell, J D Dickson, H Gerber, et al.
Virus Research|August 1, 1990
Serological analysis of duck hepatitis B virus infectionM Qiao, E J Gowans, S E Bailey, et al.
American Journal of Clinical Pathology|February 1, 1992
Differing prevalence of human papillomavirus RNA in penile dysplasias and carcinomas may reflect differing etiologiesG D Higgins, D M Uzelin, G E Phillips, et al.
Cancer|July 1, 1992
High prevalence of human papillomavirus transcripts in all grades of cervical intraepithelial glandular neoplasiaG D Higgins, G E Phillips, L A Smith, et al.
BMJ (Clinical Research Ed.)|January 27, 1990
Districts' use of thrombolytic agentsC J Burrell, J D Skehan, M L Cowley, et al.
Pageof 11